We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Generic Injectables Market (2022 Edition) - Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container Type, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2022-2027)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Executive Summary

The global generic injectables market was valued at USD 134 billion in the year 2021 with the North American region leading the regional market share. Some of the key factors driving the generic injectables market growth are the expiration of branded drug patents, rising approvals for generic injectable drugs, rising aged population and the rising prevalence of life-threatening diseases among the global population. In addition, as compared to the costs of branded drugs, generic injectables are relatively inexpensive and used in the treatment of major diseases such as cancer, cardiovascular diseases, diabetes, and so on that further supports market demand.

The Asia Pacific is estimated to be the fastest-growing region due to the growing focus of Indian companies on complex generics and the rise in the adoption of generic injectables due to its cost-efficient nature. In addition, the APAC countries (China and India) have the highest prevalent cases of different chronic diseases, which is projected to fuel the market growth in upcoming years. Meanwhile, North America will remain the dominant region in the global Generic Injectables market. The United States in the North American region and China in Asia-Pacific are the major countries in the Generic Injectables market globally.

The outbreak of COVID-19 showed an impact on the global generic injectables market because hospitals, healthcare services, and drug manufacturers were significantly affected due to a variety of restrictions imposed by governments across the globe such as social distancing, travel restrictions, border closures, restrictions on public gatherings, work from home and so on. COVID-19 has had a direct impact on both supply and demand and created disruption in the supply chain, as many injectable drugs could not reach the market on time. Although the impact of COVID-19 in the pharmaceutical industry was a bit lesser compared to other industries, it still has been harmed in some ways. Many clinical trials were delayed due to the pandemic, as researchers were not permitted to visit the laboratories and continue those ongoing trials. If there were no disruptions, those molecules would come into the market as a patented molecule, hence increasing the generic injectables market in the forecast period.

Pfizer Inc. is the world's leading generic injectables company, having strengthened its position through the introduction of several generic injectable drugs as well as mergers & partnerships with regional pharma companies. Recently in 2021, Pfizer Inc. partnered with Eli Lilly and Company, an American pharmaceutical company, to announce the approval of tanezumab, a generic injectable drug for treating osteoarthritis pain in the United States. With more branded drugs coming off patent in the coming years, Pfizer has a clear plan to develop generic versions of those injectables and obtain FDA approvals to bring them to market.

Scope of the Report

• The report analyses the Generic Injectables Market by Value (USD Billion).

• The report presents the analysis of Generic Injectables Market for the historical period of 2017-2021 and the forecast period of 2022-2027.

• The report analyses the Generic Injectables Market by Molecule Type (Small Molecule, Large Molecule).

• The report analyses the Generic Injectables Market by Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes, Others)

• The report analyses the Generic Injectables Market by Container (Vials, Ampoules, Pre-filled Syringes and Others)

• The Global Generic Injectables Market has been analysed By Region (North America, Europe, Asia Pacific, and LAMEA).

• The Global Generic Injectables Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, India, Australia).

• The key insights of the report have been presented through the frameworks of SWOT Analysis. Also, the attractiveness of the market has been presented by region, by Molecule Type, by Therapeutic Area and by Container.

• Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.

• The report tracks competitive developments, strategies, and a List of First-Time Generic Injectables Approvals in 2021. The companies analysed in the report include Pfizer Inc., Novartis, Sanofi, Baxter International, Fresenius SE & Co KGaA, Amneal Pharmaceuticals, Hikma Pharmaceuticals, Gland Pharma, Teva Pharmaceuticals and Nichi-iko Pharmaceutical.

Key Target Audience

• Injectable Drug Manufacturers & Distributors

• Pharmaceutical, Biopharmaceutical & Biotechnological Companies

• End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers & Others)

• Research and Development (R&D) Organizations

• Government Bodies & Regulating Authorities

• Investment Banks and Equity Firms

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. Generic Injectables Market: Product Overview

4. Global Generic Injectables Market: An Analysis

4.1 Market Size, By Value, 2017-2027

4.2 Global Generic Injectables Market: Growth & Forecast

4.3 Impact of COVID-19 on Generic Injectables Market

5. Global Generic Injectables Market Segmentation, By Molecule Type (Value)

5.1 Competitive Scenario of Global Generic Injectables Market: By Molecule Type

5.2 Global Generic Injectables Market: Segment Analysis

5.3 By Small Molecule - Market Size and Forecast (2017-2027)

5.4 By Large Molecule - Market Size and Forecast (2017-2027)

6. Global Generic Injectables Market Segmentation, By Therapeutic Area (Value)

6.1 Competitive Scenario of Global Generic Injectables Market: By Therapeutic Area (2021 & 2027)

6.2 Global Generic Injectables Market: Segment Analysis

6.3 By Oncology - Market Size and Forecast (2017-2027)

6.4 By Anti-infectives - Market Size and Forecast (2017-2027)

6.5 By Cardiovascular - Market Size and Forecast (2017-2027)

6.6 By Diabetes - Market Size and Forecast (2017-2027)

6.7 By Others - Market Size and Forecast (2017-2027)

7. Global Generic Injectables Market Segmentation, By Container (Value)

7.1 Competitive Scenario of Global Generic Injectables Market: By Container (2021 & 2027)

7.2 Global Generic Injectables Market: Segment Analysis

7.3 By Vials - Market Size and Forecast (2017-2027)

7.4 By Ampoules - Market Size and Forecast (2017-2027)

7.5 By Pre-filled Syringes - Market Size and Forecast (2017-2027)

7.6 By Others - Market Size and Forecast (2017-2027)

8. Global Generic Injectables Market: Regional Analysis

8.1 Competitive Scenario of Global Generic Injectables Market: By Region (2021 & 2027)

9. North America Generic Injectables Market: An Analysis (2017-2027)

9.1 North America Generic Injectables Market: Size and Forecast (2017-2027), By Value

9.2 North America Generic Injectables Market - Prominent Companies

9.3 Market Segmentation By Molecule Type (Small Molecule and Large Molecule)

9.4 Market Segmentation By Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes and Others)

9.5 Market Segmentation By Container (Vials, Ampoules, Pre-filled Syringes and Others)

9.6 North America Generic Injectables Market: Country Analysis

9.7 Market Opportunity Chart of North America Generic Injectables Market - By Country, By Value (Year-2026)

9.8 Competitive Scenario of North America- By Country

9.9 United States Generic Injectables Market: Size and Forecast (2017-2027), By Value

9.10 United States Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

9.11 Canada Generic Injectables Market: Size and Forecast (2017-2027), By Value

9.12 Canada Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

10. Europe Generic Injectables Market: An Analysis (2017-2027)

10.1 Europe Generic Injectables Market by value: Size and Forecast (2017-2027)

10.2 Europe Generic Injectables Market: Prominent Companies

10.3 Market Segmentation By Molecule Type (Small Molecule and Large Molecule)

10.4 Market Segmentation By Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes and Others)

10.5 Market Segmentation By Container (Vials, Ampoules, Pre-filled Syringes and Others)

10.6 Europe Generic Injectables Market: Country Analysis

10.7 Market Opportunity Chart of Europe Generic Injectables Market - By Country, By Value (Year-2026)

10.8 Competitive Scenario of Europe Generic Injectables Marketñ By Country (2021 & 2027)

10.9 Germany Generic Injectables Market: Size and Forecast (2017-2027)

10.10 Germany Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

10.11 United Kingdom Generic Injectables Market: Size and Forecast (2017-2027)

10.12 United Kingdom Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

10.13 France Generic Injectables Market: Size and Forecast (2017-2027)

10.14 France Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

10.15 Italy Generic Injectables Market: Size and Forecast (2017-2027)

10.16 Italy Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

11. Asia Pacific Generic Injectables Market: An Analysis (2017-2027)

11.1 Asia Pacific Generic Injectables Market by value: Size and Forecast (2017-2027)

11.2 Asia Pacific Generic Injectables Market: Prominent Companies

11.3 Market Segmentation By Molecule Type (Small Molecule and Large Molecule)

11.4 Market Segmentation By Therapeutic Area (Oncology, Anti-infectives, Cardiovascular, Diabetes and Others)

11.5 Market Segmentation By Container (Vials, Ampoules, Pre-filled Syringes and Others)

11.6 Asia Pacific Generic Injectables Market: Country Analysis

11.7 Market Opportunity Chart of Asia Pacific Generic Injectables Market - By Country, By Value (Year-2026)

11.8 Competitive Scenario of Asia Pacific Generic Injectables Market - By Country (2021 & 2027)

11.9 China Generic Injectables Market: Size and Forecast (2017-2027)

11.10 China Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

11.11 Japan Generic Injectables Market: Size and Forecast (2017-2027)

11.12 Japan Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

11.13 India Generic Injectables Market: Size and Forecast (2017-2027)

11.14 India Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

11.15 Australia Generic Injectables Market: Size and Forecast (2017-2027)

11.16 Australia Generic Injectables Market Segmentation By Molecule Type, By Therapeutic Area and By Container (2017-2027)

12. Global Generic Injectables Market Dynamics

12.1 Global Generic Injectables Market Drivers

12.2 Global Generic Injectables Market Restraints

12.3 Global Generic Injectables Market Trends

13. Market Attractiveness and Strategic Analysis

13.1 Market Attractiveness Chart of Global Generic Injectables Market - By Molecule Type (Year 2027)

13.2 Market Attractiveness Chart of Global Generic Injectables Market - By Therapeutic Area (Year 2027)

13.3 Market Attractiveness Chart of Global Generic Injectables Market ñ By Container (Year 2027)

13.4 Market Attractiveness Chart of Global Generic Injectables Market ñ By Region (Year 2027)

14. Competitive Landscape

14.1 Market Share of global leading companies

14.2 Market Share of Leading US Companies by Value & by Volume

14.3 SWOT Analysis - Global Generic Injectables Market

15. Global Generic Injectables Market: List of First-Time Generic Injectables Approvals in 2021

16. Company Profiles (Business Description, Financial Analysis, Business Strategy)

16.1 Pfizer Inc.

16.2 Novartis

16.3 Sanofi

16.4 Baxter International

16.5 Fresenius SE & Co KGaA

16.6 Amneal Pharmaceuticals

16.7 Hikma Pharmaceuticals

16.8 Gland Pharma

16.9 Teva Pharmaceuticals

16.10 Nichi-iko Pharmaceutical

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved